Pharmaceutical Technology

JULY 14, 2022

Historically, the pharmaceutical industry has failed to meet the needs of this patient population. Centralised incentives are also in place across Europe, as well as at the national level in some EU states. Go-to-market strategies. The choice of where to launch an orphan drug is an important and difficult decision.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

pharmaphorum

JANUARY 21, 2022

The Oslo Medicines Initiative (OMI), which held its first public webinar event last week, was conceived before the pandemic, but it has gained new relevance as it seeks to address this disparity in Europe, a union of countries with hugely varying income levels. WHO is OMI? The current situation, said Muscat, is “unacceptable”.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

JANUARY 27, 2023

cases per million in Europe. In an email to Pharmaceutical Technology , he further described the therapy as “the most important advance for treatment of TTP since the documentation of effectiveness of plasma exchange in 1991”. GlobalData is the parent company of Pharmaceutical Technology. However, obstacles still remain.

Documentation 52

Documentation Immunity Immunization Inpatient 52